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Janus kinases (JAKs) belong to a family of receptor-associated protein tyrosine kinases. They
play a crucial role in the JAK/STAT signaling pathways which are responsible for transduction
of growth factors and cytokine-mediated signals. Abnormal activation of these pathways is
observed in many types of tumors and hematopoetic malignancies1,2 In the current study we
attempt to propose binding modes of caffeic acid derivatives to JAK3, These derivatives are
most likely competitive inhibitors for tyrosine-containing protein substrates. Insulin Receptor
Kinase (IRK) was used to model an active, open form of JAK3. Based on JAK2 and JAK3
sequence and structure similarity analyses, residues that are responsible for the specific binding
were indicated. Leading compounds were docked and modified to get a better binding speci-
ficity. The designed inhibitors are being synthesized and their biological activity will be studied
experimentally.
1 Introduction
JAKs are crucial enzymes, responsible for the signal transduction through the JAK/STAT
pathways, whose abnormal activation is observed in many types of tumors and hematopo-
etic malignancies, making them an important, but still poorly explored target for therapeu-
tic intervention. Our goal was to create substrate competitive inhibitors of JAK3, based
on our knowledge of the JAK2 inhibitors. Caffeic acid derivatives, including AG490, are
the potential, promising inhibitors3. Even though the sequence similarity between catalytic
domains of JAK2 and JAK3 is about 60%, it is difficult to propose JAK3 specific inhibitors.
This is because essential residues (those which form the ATP binding pocket or the peptide
binding site) are mostly the same for both kinases. In addition, there are no experimental
JAK3 open (active) conformations. There is, however, an IRK structure with a bound pro-
tein inhibitor in an open enzyme conformation. Even though sequence similarity between
IRK and JAKs is relatively low, the three dimensional structure similarity is significant
(Fig. 1). Structural information and JAK2 and JAK3 sequence similarity analysis allowed
us to identify JAK3 potential binding sites and to design specific inhibitors.
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Figure 1. (A) Superposition of JAK3 on IRK. Yellow ribbon presents IRK, blue ribbon presents JAK3. The green
spacefill atoms represent protein substrate atoms while the red spacefill atoms represent ANP (the ATP analog
which is bound in the ATP binding cassette). (B) JAK3. The arrow indicates the nucleotide binding site, rectangle
indicates the predicted docking sites.
2 Materials and Methods
Three dimensional structures of IRK, JAK3 as well as of JAK2 from the Protein Data
Base were used (1IR3, 1YVJ and 2B7A structures, respectively). Because JAKs do not
contain peptide substrates/inhibitors, the IRK structure in its open, active form was used
for the identification of the JAK3 ligand binding site. Using MOE software we docked our
potential inhibitors in the predicted peptide binding site as indicated by rectangle in Fig. 1.
Because the site is relatively large, we identified two subsites that fit to our ligands. These
two subsites are located in the top part and in the bottom part of the rectangle.
3 Results and Discussion
We attempted to design inhibitors that form hydrogen bonds with the backbone as well as
with proteins side chains. The H-bonds with the backbone are responsible for the bind-
ing efficacy, and the H-bonds with the side chains are responsible for the substrate speci-
ficity. We indentified four potential binding sites, two of them appeared to be very promis-
ing. These are the second (Site2) and the fourth (Site4) largest pockets detected on the
JAK3 surface. The most important residues which form the Site2 are: ALA952 Cys1024,
ASP1025, CYS1028 and SER1031. In turn, ARG984, ASN1002 and LEU1047 form the
Site4. The first binding mode accounts for interactions with the backbone of SER1029
and Ser1031. In JAK2 these positions are occupied by SER1056 and PRO1058 respec-
tively. The second binding mode in JAK3 accounts for interactions with the backbone
of ASN1002, which in JAK2 is occupied by SER1029 and SER 998. These two binding
modes (Fig. 2) appeared to be the most promising. Concluding, it was possible to identify
those JAK3 residues that are potentially responsible for the substrate/ligand specificity.
In order to get sufficiently high specificity of the potential inhibitors one can generate
and visualize sequence variability profiles for a given protein family. Regarding protein
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Figure 2. Binding of the caffeic acid derivatives to two subsites (A and B) in JAK3. The arrows represent the
modelled hydrogen bonds that link JAK3 with added/modified atoms of the ligand.
Figure 3. (A) Variability profiles resulting from alignment of 152 protein sequences from the PFAM database
for the JAK family, using the JAK3 structure for visualization. (B) Visualization of 50 protein Homo sapiens
sequences homologous to JAK3 acquired from the SWISS-PROT/TREMBL database. Each color represents
a number of different amino acids which occupy a particular position in the multiple sequence alignment. In
addition, the green color represents ATP and the protein C and N ends.
kinases, sequences from PFAM4 and from Swiss-Prot/Trembl5 data bases were used. A
new application6 processes these sequences and visualizes variability profiles in 3D on a
2D surface of the studied enzyme here JAK3, presented in Fig. 3. The mentioned above
analysis can account for hundreds of protein sequences, it is very fast and brings a lot of
essential data.
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